Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care

por Karzai, Fatima, Dahut, William L.
Publicado 2022

Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises

por Aragon-Ching, Jeanny B., Madan, Ravi A., Dahut, William L.
Publicado 2010

Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine

por Madan, Ravi A., Redman, Jason M., Karzai, Fatima, Dahut, William L., Cordes, Lisa, Fakhrejahani, Farhad, Vu, Tuyen, Sheikh, Nadeem, Schlom, Jeffrey, Gulley, James L.
Publicado 2023

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

por English, Bevin C, Baum, Caitlin E, Adelberg, David E, Sissung, Tristan M, Kluetz, Paul G, Dahut, William L, Price, Douglas K, Figg, William D
Publicado 2010

Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment

por Lee, Sungwon, Elton, Daniel C., Gulley, James L., Pickhardt, Perry J., Dahut, William L., Madan, Ravi A., Pinto, Peter A., Citrin, Deborah E., Summers, Ronald M.
Publicado 2022

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

por Del Rivero, Jaydira, Donahue, Renee N., Marté, Jennifer L., Gramza, Ann W., Bilusic, Marijo, Rauckhorst, Myrna, Cordes, Lisa, Merino, Maria J., Dahut, William L., Schlom, Jeffrey, Gulley, James L., Madan, Ravi A.
Publicado 2020

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

por Bilusic, Marijo, Toney, Nicole J., Donahue, Renee N., Wroblewski, Susan, Zibelman, Matthew, Ghatalia, Pooja, Ross, Eric A., Karzai, Fatima, Madan, Ravi A., Dahut, William L., Gulley, James L., Schlom, Jeffrey, Plimack, Elizabeth R., Geynisman, Daniel M.
Publicado 2022

Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

por Jain, Lokesh, Sissung, Tristan M, Danesi, Romano, Kohn, Elise C, Dahut, William L, Kummar, Shivaani, Venzon, David, Liewehr, David, English, Bevin C, Baum, Caitlin E, Yarchoan, Robert, Giaccone, Giuseppe, Venitz, Jürgen, Price, Douglas K, Figg, William D
Publicado 2010

Deep Learning Based Staging of Bone Lesions From Computed Tomography Scans

por MASOUDI, SAMIRA, MEHRALIVAND, SHERIF, HARMON, STEPHANIE A., LAY, NATHAN, LINDENBERG, LIZA, MENA, ESTHER, PINTO, PETER A., CITRIN, DEBORAH E., GULLEY, JAMES L., WOOD, BRADFORD J., DAHUT, WILLIAM L., MADAN, RAVI A., BAGCI, ULAS, CHOYKE, PETER L., TURKBEY, BARIS
Publicado 2021

Samarium-153-EDTMP (Quadramet(®)) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial

por Heery, Christopher R., Madan, Ravi A., Stein, Mark N., Stadler, Walter M., Di Paola, Robert S., Rauckhorst, Myrna, Steinberg, Seth M., Marté, Jennifer L., Chen, Clara C., Grenga, Italia, Donahue, Renee N., Jochems, Caroline, Dahut, William L., Schlom, Jeffrey, Gulley, James L.
Publicado 2016

A comparison of prostate cancer bone metastases on (18)F-Sodium Fluoride and Prostate Specific Membrane Antigen ((18)F-PSMA) PET/CT: Discordant uptake in the same lesion

por Harmon, Stephanie A., Mena, Esther, Shih, Joanna H., Adler, Stephen, McKinney, Yolanda, Bergvall, Ethan, Mehralivand, Sherif, Sowalsky, Adam G., Couvillon, Anna, Madan, Ravi A., Gulley, James L., Eary, Janet, Mease, Ronnie C., Pomper, Martin G., Dahut, William L., Turkbey, Baris, Lindenberg, Liza, Choyke, Peter L.
Publicado 2018

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

por Abdul Sater, Houssein, Marté, Jennifer L, Donahue, Renee N, Walter-Rodriguez, Beatriz, Heery, Christopher R, Steinberg, Seth M, Cordes, Lisa M, Chun, Guinevere, Karzai, Fatima, Bilusic, Marijo, Harmon, Stephanie A, Turkbey, Ismail Baris, Choyke, Peter L, Schlom, Jeffrey, Dahut, William L, Madan, Ravi A, Pinto, Peter A, Gulley, James L
Publicado 2020

A case report of multiple primary prostate tumors with differential drug sensitivity

por Wilkinson, Scott, Harmon, Stephanie A., Terrigino, Nicholas T., Karzai, Fatima, Pinto, Peter A., Madan, Ravi A., VanderWeele, David J., Lake, Ross, Atway, Rayann, Bright, John R., Carrabba, Nicole V., Trostel, Shana Y., Lis, Rosina T., Chun, Guinevere, Gulley, James L., Merino, Maria J., Choyke, Peter L., Ye, Huihui, Dahut, William L., Turkbey, Baris, Sowalsky, Adam G.
Publicado 2020

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

por Karzai, Fatima, VanderWeele, David, Madan, Ravi A., Owens, Helen, Cordes, Lisa M., Hankin, Amy, Couvillon, Anna, Nichols, Erin, Bilusic, Marijo, Beshiri, Michael L., Kelly, Kathleen, Krishnasamy, Venkatesh, Lee, Sunmin, Lee, Min-Jung, Yuno, Akira, Trepel, Jane B., Merino, Maria J., Dittamore, Ryan, Marté, Jennifer, Donahue, Renee N., Schlom, Jeffrey, Killian, Keith J., Meltzer, Paul S., Steinberg, Seth M., Gulley, James L., Lee, Jung-Min, Dahut, William L.
Publicado 2018

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

por Dinstag, Gal, Shulman, Eldad D., Elis, Efrat, Ben-Zvi, Doreen S., Tirosh, Omer, Maimon, Eden, Meilijson, Isaac, Elalouf, Emmanuel, Temkin, Boris, Vitkovsky, Philipp, Schiff, Eyal, Hoang, Danh-Tai, Sinha, Sanju, Nair, Nishanth Ulhas, Lee, Joo Sang, Schäffer, Alejandro A., Ronai, Ze’ev, Juric, Dejan, Apolo, Andrea B., Dahut, William L., Lipkowitz, Stanley, Berger, Raanan, Kurzrock, Razelle, Papanicolau-Sengos, Antonios, Karzai, Fatima, Gilbert, Mark R., Aldape, Kenneth, Rajagopal, Padma S., Beker, Tuvik, Ruppin, Eytan, Aharonov, Ranit
Publicado 2023

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

por Sowalsky, Adam G., Figueiredo, Ines, Lis, Rosina T., Coleman, Ilsa, Gurel, Bora, Bogdan, Denisa, Yuan, Wei, Russo, Joshua W., Bright, John R., Whitlock, Nichelle C., Trostel, Shana Y., Ku, Anson T., Patel, Radhika A., True, Lawrence D., Welti, Jonathan, Jimenez-Vacas, Juan M., Rodrigues, Daniel Nava, Riisnaes, Ruth, Neeb, Antje, Sprenger, Cynthia T., Swain, Amanda, Wilkinson, Scott, Karzai, Fatima, Dahut, William L., Balk, Steven P., Corey, Eva, Nelson, Peter S., Haffner, Michael C., Plymate, Stephen R., de Bono, Johann S., Sharp, Adam
Publicado 2022

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020